Connect your AI

United Therapeutics UTHR Total Liabilities

Total Liabilities at other companies

Tenet HealthcareTHC

$22.35B+8.6%

Johnson & JohnsonJNJ

$116.09B+1.0%

Merck & Co.MRK

$229M—

InsmedINSM

$1.37B-19.5%

LQD

Liquidia CorporationLQDA

$292.95M+64.8%

AmgenAMGN

——

Other financials

Income statement

Revenue$781.5M-1.6%

Gross profit$648.1M-7.7%

Operating income$325.8M-14.9%

Net income$274.9M-14.7%

EPS (diluted)$5.82-12.2%

Balance sheet

Cash & equivalents$1.3B-32.6%

Total debt$12.2M—

Total equity$5.9B-13.3%

Total assets$6.7B-13.3%

Cash flow

Operating cash flow$463.3M+0.5%

CapEx$100.8M+34.6%

Free cash flow$362.5M-6.2%

Valuation

Market cap$26.25B+90.4%

P/E20.4×+9.3×

P/S8.3×+3.8×

Profitability

Gross margin86.6%-2.4pp

Operating margin45.3%-1.6pp

Net margin40.6%+0.2pp

FCF margin32.1%-5.6pp

Returns & leverage

Return on equity20.3%+0.3pp

Debt / equity0×—

Current ratio4.8×-0.7×

Where this comes from

Reported directly by United Therapeutics in its filing.

Tagged under the XBRL concept us-gaap:Liabilities.

The official record: United Therapeutics’s 10-Q, filed May 6, 2026, on SEC EDGAR. View the filing →

Ask your AI about United Therapeutics's total liabilities.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI

Harbor at dusk

Questions, answered.

What is United Therapeutics's total liabilities?: United Therapeutics (UTHR) reported total liabilities of $813.1M in Q1 2026.
How has United Therapeutics's total liabilities changed year-over-year?: United Therapeutics's total liabilities decreased by 13.2% year-over-year, from $936.7M to $813.1M.
What is the long-term trend for United Therapeutics's total liabilities?: Over 5 years (2020 to 2025), United Therapeutics's total liabilities has grown at a -8.5% compound annual growth rate (CAGR), from $1.22B to $783.8M.
What does total liabilities mean?: The sum of all current and non-current obligations — everything the company owes to creditors, employees, governments, and other stakeholders.